{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:48:13Z","timestamp":1790117293582,"version":"4.0.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Experimental autoimmune encephalomyelitis (EAE) is a T cell-mediated autoimmune disease of the CNS. Metformin is the most widely used drug for diabetes and mediates its action via activating AMP-activated protein kinase (AMPK). We provide evidence that metformin attenuates the induction of EAE by restricting the infiltration of mononuclear cells into the CNS, down-regulating the expression of proinflammatory cytokines (IFN-\u03b3, TNF-\u03b1, IL-6, IL-17, and inducible NO synthase (iNOS)), cell adhesion molecules, matrix metalloproteinase 9, and chemokine (RANTES). Furthermore, the AMPK activity and lipids alterations (total phospholipids and in free fatty acids) were restored by metformin treatment in the CNS of treated EAE animals, suggesting the possible involvement of AMPK. Metformin activated AMPK in macrophages and thereby inhibited biosynthesis of phospholipids as well as neutral lipids and also down-regulated the expression of endotoxin (LPS)-induced proinflammatory cytokines and their mediators (iNOS and cyclooxygenase 2). It also attenuated IFN-\u03b3 and IL-17-induced iNOS and cyclooxygenase 2 expression in RAW267.4 cells, further supporting its anti-inflammatory property. Metformin inhibited T cell-mediated immune responses including Ag-specific recall responses and production of Th1 or Th17 cytokines, while it induced the generation of IL-10 in spleen cells of treated EAE animals. Altogether these findings reveal that metformin may have a possible therapeutic value for the treatment of multiple sclerosis and other inflammatory diseases.<\/jats:p>","DOI":"10.4049\/jimmunol.0803563","type":"journal-article","created":{"date-parts":[[2009,6,3]],"date-time":"2009-06-03T20:48:22Z","timestamp":1244062102000},"page":"8005-8014","source":"Crossref","is-referenced-by-count":318,"title":["Metformin Attenuated the Autoimmune Disease of the Central Nervous System in Animal Models of Multiple Sclerosis"],"prefix":"10.1093","volume":"182","author":[{"given":"Narender","family":"Nath","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Medical University of South Carolina , Charleston, SC 29425"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musfiquidin","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical University of South Carolina , Charleston, SC 29425"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjeet K","family":"Paintlia","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical University of South Carolina , Charleston, SC 29425"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Nasrul","family":"Hoda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical University of South Carolina , Charleston, SC 29425"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra","family":"Giri","sequence":"additional","affiliation":[{"name":"Department of Experimental Pathology, Mayo Clinic , Rochester, MN 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,6,15]]},"reference":[{"key":"2025032715465566400_R1","first-page":"683","article-title":"Immunology of multiple sclerosis.","volume-title":"Annu. Rev. Immunol.","year":"2005"},{"key":"2025032715465566400_R2","first-page":"685","article-title":"Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis.","volume-title":"Neuron","year":"2003"},{"key":"2025032715465566400_R3","first-page":"759","article-title":"Autoimmune diseases: genes, bugs and failed regulation.","volume-title":"Nat. Immunol.","year":"2001"},{"key":"2025032715465566400_R4","first-page":"220","article-title":"T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis.","volume-title":"Glia","year":"2001"},{"key":"2025032715465566400_R5","first-page":"5536","article-title":"Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis.","volume-title":"J. Immunol.","year":"1995"},{"key":"2025032715465566400_R6","first-page":"511","article-title":"Assessment of animal models for MS and demyelinating disease in the design of rational therapy.","volume-title":"Neuron","year":"1999"},{"key":"2025032715465566400_R7","first-page":"1420","article-title":"Adoptive transfer of experimental allergic encephalomyelitis in SJL\/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+2\u2212 T lymphocytes.","volume-title":"J. Immunol.","year":"1981"},{"key":"2025032715465566400_R8","first-page":"34","article-title":"Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.","volume-title":"Immunol. Today","year":"1995"},{"key":"2025032715465566400_R9","first-page":"579","article-title":"The T lymphocyte in experimental allergic encephalomyelitis.","volume-title":"Annu. Rev. Immunol.","year":"1990"},{"key":"2025032715465566400_R10","first-page":"213","article-title":"Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10.","volume-title":"J. Neuroimmunol.","year":"1993"},{"key":"2025032715465566400_R11","first-page":"1123","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.","volume-title":"Nat. Immunol.","year":"2005"},{"key":"2025032715465566400_R12","first-page":"1133","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.","volume-title":"Nat. Immunol.","year":"2005"},{"key":"2025032715465566400_R13","first-page":"233","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.","volume-title":"J. Exp. Med.","year":"2005"},{"key":"2025032715465566400_R14","first-page":"5043","article-title":"Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin.","volume-title":"J. Clin. Endocrinol. Metab.","year":"2004"},{"key":"2025032715465566400_R15","first-page":"611","article-title":"Metformin inhibits proinflammatory responses and nuclear factor-\u03baB in human vascular wall cells.","volume-title":"Arterioscler. Thromb. Vasc. Biol.","year":"2006"},{"key":"2025032715465566400_R16","first-page":"998","article-title":"Metformin reverses fatty liver disease in obese, leptin-deficient mice.","volume-title":"Nat. Med.","year":"2000"},{"key":"2025032715465566400_R17","first-page":"120","article-title":"Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells.","volume-title":"Diabetes","year":"2006"},{"key":"2025032715465566400_R18","first-page":"829","article-title":"Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells.","volume-title":"Metabolism","year":"2005"},{"key":"2025032715465566400_R19","first-page":"379","article-title":"Metformin attenuates blood lipid peroxidation and potentiates antioxidant defense in high fructose-fed rats.","volume-title":"J. Biochem. Mol. Biol. Biophys.","year":"2002"},{"key":"2025032715465566400_R20","first-page":"53","article-title":"Insulin resistance as a therapeutic target for improved endothelial function: metformin.","volume-title":"Curr. Drug Targets Cardiovasc. Haematol. Disord.","year":"2004"},{"key":"2025032715465566400_R21","first-page":"749","article-title":"Metformin administration improves endothelial function in women with polycystic ovary syndrome.","volume-title":"Eur. J. Endocrinol.","year":"2005"},{"key":"2025032715465566400_R22","first-page":"2615","article-title":"Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats.","volume-title":"Life Sci.","year":"2006"},{"key":"2025032715465566400_R23","first-page":"496","article-title":"Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase.","volume-title":"Diabetes","year":"2006"},{"key":"2025032715465566400_R24","first-page":"25226","article-title":"The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.","volume-title":"J. Biol. Chem.","year":"2002"},{"key":"2025032715465566400_R25","first-page":"2420","article-title":"The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism.","volume-title":"Diabetes","year":"2002"},{"key":"2025032715465566400_R26","first-page":"1167","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action.","volume-title":"J. Clin. Invest.","year":"2001"},{"key":"2025032715465566400_R27","first-page":"303","article-title":"Metformin: a review.","volume-title":"Drugs Today","year":"2008"},{"key":"2025032715465566400_R28","first-page":"479","article-title":"5-Aminoimidazole-4-carboxamide-1-\u03b2-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase.","volume-title":"J. Neurosci.","year":"2004"},{"key":"2025032715465566400_R29","first-page":"566","article-title":"5-Aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.","volume-title":"J. Immunol.","year":"2005"},{"key":"2025032715465566400_R30","first-page":"1273","article-title":"Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy.","volume-title":"J. Immunol.","year":"2004"},{"key":"2025032715465566400_R31","first-page":"1478","article-title":"Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death.","volume-title":"J Lipid Res.","year":"2006"},{"key":"2025032715465566400_R32","first-page":"41","article-title":"Endotoxin-induced alterations of lipid and fatty acid compositions in rat liver peroxisomes.","volume-title":"J. Endotoxin Res.","year":"2000"},{"key":"2025032715465566400_R33","first-page":"460","article-title":"The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE).","volume-title":"Autoimmun. Rev.","year":"2005"},{"key":"2025032715465566400_R34","first-page":"167","article-title":"Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome.","volume-title":"J. Immunother.","year":"1992"},{"key":"2025032715465566400_R35","first-page":"12","article-title":"The cytokine storm in multiple sclerosis.","volume-title":"Mult. Scler.","year":"1998"},{"key":"2025032715465566400_R36","first-page":"423","article-title":"Central nervous system endothelium in neuroinflammatory, neuroinfectious, and neurodegenerative disease.","volume-title":"J. Neurosci. Res.","year":"1998"},{"key":"2025032715465566400_R37","first-page":"1717","article-title":"The blood-brain barrier and multiple sclerosis.","volume-title":"Biochem. Pharmacol.","year":"1994"},{"key":"2025032715465566400_R38","first-page":"77","article-title":"Adhesion molecule expression and regulation on cells of the central nervous system.","volume-title":"J. Neuroimmunol.","year":"1999"},{"key":"2025032715465566400_R39","first-page":"89","article-title":"Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis.","volume-title":"Ann. Neurol.","year":"1994"},{"key":"2025032715465566400_R40","first-page":"129","article-title":"Expression of ICAM-1, VCAM-1, L-selectin, and leukosialin in the mouse central nervous system during the induction and remission stages of experimental allergic encephalomyelitis.","volume-title":"J. Neuroimmunol.","year":"1994"},{"key":"2025032715465566400_R41","first-page":"1074","article-title":"Downregulation of cellular energy sensor during disease condition results in alteration of lipid homeostasis in immune cells.","volume-title":"FASEB J.","year":"2008"},{"key":"2025032715465566400_R42","first-page":"574","article-title":"Metformin.","volume-title":"N. Engl. J. Med.","year":"1996"},{"key":"2025032715465566400_R43","first-page":"179","article-title":"Metformin and lactic acidosis: cause or coincidence? A review of case reports.","volume-title":"J Intern. Med.","year":"2004"},{"key":"2025032715465566400_R44","first-page":"1183","article-title":"Metformin inhibits cytokine-induced nuclear factor \u03baB activation via AMP-activated protein kinase activation in vascular endothelial cells.","volume-title":"Hypertension","year":"2006"},{"key":"2025032715465566400_R45","first-page":"395","article-title":"Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.","volume-title":"Diabetes Metab.","year":"2007"},{"key":"2025032715465566400_R46","first-page":"774","article-title":"AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy.","volume-title":"Nat. Rev. Mol. Cell Biol.","year":"2007"},{"key":"2025032715465566400_R47","first-page":"8633","article-title":"Adenosine 5\u2032-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype.","volume-title":"J. Immunol.","year":"2008"},{"key":"2025032715465566400_R48","first-page":"1535","article-title":"IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.","volume-title":"J. Exp. Med.","year":"2008"},{"key":"2025032715465566400_R49","first-page":"761","article-title":"Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae.","volume-title":"J. Exp. Med.","year":"2005"},{"key":"2025032715465566400_R50","first-page":"231","article-title":"Transforming growth factor-\u03b2 induces development of the TH17 lineage.","volume-title":"Nature","year":"2006"},{"key":"2025032715465566400_R51","first-page":"648","article-title":"Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.","volume-title":"Nature","year":"2007"},{"key":"2025032715465566400_R52","first-page":"3943","article-title":"The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial.","volume-title":"J. Clin. Endocrinol. Metab.","year":"2004"},{"key":"2025032715465566400_R53","first-page":"100","article-title":"Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.","volume-title":"J. Intern. Med.","year":"2005"},{"key":"2025032715465566400_R54","first-page":"122","article-title":"CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis: an intravital microscopy study.","volume-title":"J. Neuroimmunol.","year":"2005"},{"key":"2025032715465566400_R55","first-page":"933","article-title":"Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells: essential roles of a variant NF-\u03baB site and p65 homodimers.","volume-title":"J. Biol. Chem.","year":"1995"},{"key":"2025032715465566400_R56","first-page":"1583","article-title":"Functional analysis of the human vascular cell adhesion molecule 1 promoter.","volume-title":"J. Exp. Med.","year":"1992"},{"key":"2025032715465566400_R57","first-page":"5820","article-title":"Three NF-\u03baB binding sites in the human E-selectin gene required for maximal tumor necrosis factor \u03b1-induced expression.","volume-title":"Mol. Cell. Biol.","year":"1994"},{"key":"2025032715465566400_R58","first-page":"614","article-title":"5-Aminoimidazole-4-carboxamide-1-\u03b2-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.","volume-title":"J. Neurosci. Res.","year":"2006"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/182\/12\/8005\/62686997\/9136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/182\/12\/8005\/62686997\/9136.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T16:39:30Z","timestamp":1743352770000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/182\/12\/8005\/8007140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,6,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.0803563","relation":{},"ISSN":["1550-6606","0022-1767"],"issn-type":[{"value":"1550-6606","type":"electronic"},{"value":"0022-1767","type":"print"}],"subject":[],"published-other":{"date-parts":[[2009,6]]},"published":{"date-parts":[[2009,6]]}}}